Peptides: Epitalon Overview — Telomerase-Activating Tetrapeptide
Khavinson 2002 (PMID 12386740): epitalon (Ala-Glu-Asp-Gly) restored telomerase activity in human somatic cells and extended rodent lifespan by 13–24% in controlled studies. Grade B (Russian clinical).
| Measure | Value | Unit | Notes |
|---|---|---|---|
| Evidence Grade | B/C | grade | Grade B by Russian clinical and regulatory standards; Grade C by Western peer-review — most data from Khavinson's group |
| Peptide Sequence | Ala-Glu-Asp-Gly | tetrapeptide | 4 amino acid synthetic tetrapeptide; also known as Epithalamin synthetic analogue; identical to native pineal peptide epitalamin |
| Rodent Lifespan Extension | 13–24 | % increase | Anisimov 2003 (PMID 14501183): female SHR mice treated with epitalon showed 13–24% longer mean lifespan vs control |
| Telomerase Activation | Confirmed in vitro | cell study | PMID 12386740: human embryonic kidney and somatic cells showed telomerase activity restoration after epitalon treatment |
| Tumor Incidence (rodent) | Reduced | vs control | PMID 14501183: spontaneous tumor incidence was lower in epitalon-treated mice — consistent with geroprotective profile |
| Origin | 1980s | development decade | Developed by Vladimir Khavinson at Institute of Bioregulation and Gerontology, St. Petersburg; based on pineal gland extract research |
| Human Trials | Limited | status | Small Russian observational studies in elderly patients; no large RCTs; no Western peer-reviewed trials |
Epitalon: Pineal-Derived Longevity Tetrapeptide
Epitalon (also spelled Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly, developed by Vladimir Khavinson at the Institute of Bioregulation and Gerontology in St. Petersburg, Russia. It is a synthetic analogue of epithalamin, a natural polypeptide extracted from the pineal gland of cattle, which showed geroprotective effects in animal studies beginning in the 1970s and 1980s.
Khavinson’s hypothesis is that short peptide bioregulators (2–4 amino acids) act as epigenetic switches that restore gene expression patterns associated with youth, counteracting age-related deterioration. Epitalon is the most studied of these bioregulator peptides, with over four decades of research from Khavinson’s group — though with limited independent replication.
Evidence Summary Table
| Study | Model | Key Finding | PMID |
|---|---|---|---|
| Khavinson 2003 | Human cell culture (in vitro) | Telomerase activation; telomere elongation in somatic cells | 12386740 |
| Anisimov 2003 | Female SHR mice (in vivo) | 13–24% lifespan extension; reduced spontaneous tumor incidence | 14501183 |
| Khavinson 2009 | Review — rodent + limited human observational | Biomarker improvements in elderly; neuroendocrine restoration | 20021404 |
| Human RCTs (Western) | N/A | No registered trials | — |
| Independent rodent replication | Minimal | One or two independent groups; inconsistent methodology | — |
Geroprotective Mechanism Table
| Proposed Mechanism | Evidence Level | Supporting Data | Caveat |
|---|---|---|---|
| Telomerase activation | C (in vitro) | PMID 12386740: human cells | Cell culture only; not confirmed in vivo in humans |
| Lifespan extension | C (rodent) | PMID 14501183: 13–24% in SHR mice | Rodent model; SHR strain specifics may limit generalizability |
| Antioxidant activity | C (rodent) | Oxidative stress markers improved in aged rodents | Multiple Khavinson studies; limited external replication |
| Neuroendocrine restoration | C (limited human observational) | Melatonin, cortisol normalization in elderly | Small studies; no placebo control |
| Tumor incidence reduction | C (rodent) | PMID 14501183: lower spontaneous tumors in treated mice | Rodent model; not human data |
| Circadian rhythm regulation | D (proposed) | Pineal origin = melatonin system proximity; proposed mechanism | Hypothesis only |
Epitalon vs Related Longevity Peptides
| Peptide | Mechanism | Lifespan Evidence | Human Data | Evidence Grade |
|---|---|---|---|---|
| Epitalon | Telomerase activation; geroprotection | Rodent: +13–24% (PMID 14501183) | Limited observational | B (Russian), C (Western) |
| Humanin | Mitochondrial-derived; anti-apoptotic | Rodent neuroprotection; lifespan correlation | Age-related decline (PMID 27151978) | C |
| SS-31 (Elamipretide) | Cardiolipin-targeting; mitochondrial | No lifespan extension data; disease reversal | Phase 2/3 (Barth syndrome, HF) | B |
| GHK-Cu | Collagen synthesis; anti-inflammatory | No lifespan extension data | Topical human data | B (topical) |
| BPC-157 | Tissue repair; anti-inflammatory | No lifespan data | No human RCT | C |
Legal and Regulatory Status
| Jurisdiction | Status | Notes |
|---|---|---|
| USA | Research chemical | Unscheduled; no FDA approval; no DEA scheduling |
| UK | Not scheduled | No MHRA approved product; legal to possess for research |
| Australia | Not TGA-listed | No approved ARTG entry; import for personal use gray area |
| Canada | Gray market | No DIN; Health Canada no approved product |
| EU | Not EMA-approved | Not harmonized across EU; no member state approval known |
| Russia | Research context | Khavinson’s clinical work is within institutional research; not a licensed Rx drug |
Evidence Grade Callout
Grade B (Russian) — Khavinson’s research group has conducted over 40 years of systematic peptide bioregulator research, including controlled animal studies, cell culture mechanistic work, and small human observational studies. The volume and consistency of this single group’s data warrants Grade B within its institutional context.
Grade C (Western peer-review) — Independent replication of Khavinson’s findings is limited. The human data is observational and small. No Western RCT has been conducted. Telomerase activation in cell culture does not confirm clinical longevity benefit. Western practitioners and researchers should treat epitalon as Grade C.
Legal Disclaimer
Epitalon is not approved by the FDA, EMA, TGA, or Health Canada for any indication. It is a research chemical in most jurisdictions. The telomere and lifespan findings from Khavinson’s research have not been independently replicated in large controlled human trials. This page is for educational purposes and does not constitute medical advice.
Related Pages
Sources
- Khavinson VKh et al. Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-2. PMID 12386740
- Anisimov VN et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. PMID 14501183
- Khavinson V et al. Peptide regulation of aging. Curr Aging Sci. 2009;2(3):162-8. PMID 20021404
Frequently Asked Questions
What is the connection between Epitalon and the pineal gland?
Epitalon was derived from research on Epithalamin, a polypeptide extract from bovine pineal glands that showed geroprotective effects in Khavinson's early studies. The pineal gland produces melatonin and various bioactive peptides; epithalamin (the polypeptide extract) demonstrated lifespan-extending effects in rodent studies. Epitalon (Ala-Glu-Asp-Gly) is the synthetic tetrapeptide analogue designed to replicate the active sequence from epithalamin, allowing consistent, reproducible synthesis without animal-derived extracts.
Is Epitalon's telomerase activation clinically meaningful?
Telomerase activation in isolated cell cultures (PMID 12386740) is a laboratory finding, not a clinical outcome. In human biology, telomere shortening is one mechanism of cellular aging, but telomere lengthening in isolation does not equate to meaningful anti-aging benefit and could theoretically increase cancer risk if unregulated. The telomerase finding is scientifically interesting but its clinical translation to humans has not been studied in controlled trials. The connection between laboratory telomerase activation and human longevity outcomes is speculative.
How reliable is Khavinson's research?
Vladimir Khavinson's research group at the St. Petersburg Institute of Bioregulation and Gerontology is prolific — over 40 years of peptide bioregulator research. This research has been published in peer-reviewed journals including Biogerontology and Bulletin of Experimental Biology and Medicine. However, the vast majority of human and animal studies come from this single research group with limited independent replication. The gerontology and Western peptide communities have noted this lack of independent validation. Grade B (Russian) reflects the volume and longevity of Khavinson's own data; Grade C reflects the absence of independent replication.